Weight Watchers

Oprah Winfrey To Spotlight Weight Loss Drugs In New TV Special: Will 'Shame, Blame' Come To Drug Companies — Or Could They Get Another Lift?

Goldman Sachs Thesis On Weight Watchers Is 'Absurd,' Fund Manager Says Why He'd Short The Stock

FDA-Approved Weight Loss Drug Plenity's Parent Announces SPAC Deal: What Investors Should Know

Goldman Sachs Thesis On Weight Watchers Is 'Absurd,' Fund Manager Says Why He'd Short The Stock

FDA-Approved Weight Loss Drug Plenity's Parent Announces SPAC Deal: What Investors Should Know

WW CEO Talks New Digital 360 App-Based Initiative

Why Weight Watchers Could Post 10% Subscriber Growth

WW CEO Talks New Digital 360 App-Based Initiative

Why Weight Watchers Could Post 10% Subscriber Growth

3 Stocks On The Move In The New Year

Barron's Picks And Pans: Conagra, JPMorgan, L Brands, Weight Watchers And More

Weight Watchers Recent News

Kate Hudson Teams With Oprah Winfrey To Power Shares Higher

Oprah's Weight Loss Is Weight Watchers Gain

This Woman Claims Weight Watchers Made Her Fatter

Weight Watchers Spikes, Indiana University School Of Medicine Publishes Favorable Findings

Weight Watchers Continues Surging, Investors Loving Oprah's Latest Advertisement

Vetr Crowd Upgrades Weight Watchers To 3-Star Rating

Vetr Crowd Upgrades Weight Watchers, Sees Even More Upside Coming

How Oprah Could Push Weight Watchers' Stock To $19

The Oprah Touch: Weight Watchers Skyrockets After Icon Takes Stake

Wedbush Sees Downside To Weight Watchers International, Inc. Stock Price

Market Wrap For February 14: Markets End The Week Positive

#PreMarket Primer: Friday, February 14: A Turnaround

Barron's Recap: The 2014 Roundtable, Part 3

Barron's Recap: Beware Falling Profit Estimates

LifeTime Fitness Tumbles as Americans Avoid the Gym

Barron's Recap (9/8/12): Home Prices Headed Up

Earnings Expectations for the Week of August 1

Earnings Preview for Weight Watchers (WTW)

JP Morgan Raises PT On Weight Watchers To $65

Weight Watchers Hits 52-Week High (WTW)